The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Calidi Biotherapeutics Inc (AMEX: CLDI) was $1.32 for the day, up 25.71% from the previous closing price of $1.05. In other words, the price has increased by $25.71 from its previous closing price. On the day, 9.52 million shares were traded.
Ratios:
Our analysis of CLDI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.19 and its Current Ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 22, 2023, initiated with a Buy rating and assigned the stock a target price of $11.
On October 09, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $9.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 17 ’24 when Camaisa Allan sold 10,000 shares for $1.62 per share. The transaction valued at 16,200 led to the insider holds 66,712 shares of the business.
Stock Price History:
Over the past 52 weeks, CLDI has reached a high of $16.80, while it has fallen to a 52-week low of $0.58. The 50-Day Moving Average of the stock is -7.15%, while the 200-Day Moving Average is calculated to be -17.08%.
Shares Statistics:
A total of 93.11M shares are outstanding, with a floating share count of 16.88M. Insiders hold about 10.45% of the company’s shares, while institutions hold 2.47% stake in the company.
